Subscribe To
GNOM / 3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years
GNOM News
By Seeking Alpha
May 28, 2023
GNOM: A Genomics ETF That Will Have Its Day, Even If Not Right Now
GNOM is a $200 million ETF that invests in a forward-looking set of innovative businesses focused on the genomics industry. This is a long-term growth more_horizontal
By InvestorPlace
March 15, 2023
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these excha more_horizontal
By Seeking Alpha
January 18, 2023
GNOM: Get Exposure To The Latest Genomics And Biotechnology Companies
The Global X Genomics & Biotechnology ETF tracks the Solactive Genomics Index. It invests in genomics and biotechnology companies. The fund is highly more_horizontal
By InvestorPlace
January 18, 2023
3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years
CRISPR could revolutionize the way we treat thousands of diseases. Many of these diseases occur when mutations affect genes, or when people have the more_horizontal
By Seeking Alpha
August 27, 2022
Why Now Could Be The Time To Consider Neuroscience Investments
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus more_horizontal
By Seeking Alpha
March 24, 2022
GNOM: Poor Historical Performance, Lack Of Focus, Uncertain Future
GNOM lacks efficient portfolio reshuffling and may not be able to gain from higher alpha-producing stocks in the near future. more_horizontal